STOCK TITAN

Evogene to Hold Virtual Investor & Analyst Days

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

REHOVOT, Israel, April 7, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars.

Evogene Logo

The meetings will feature key-note presentations from Evogene's CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session.

 

Questions to the speakers may be sent in advance of the event via the registration link or to ir@evogene.com or may be sent via the Question and Answer link in the zoom webinar during the event.

About Evogene Ltd.:

Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform.  The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements.  Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd.

 

Evogene Investor Contact:

US Investor Relations:



Rivka Neufeld / Aviva Banczewski 

Joseph Green

Investor Relations

Edison Group

E: IR@evogene.com

E: jgreen@edisongroup.com

T: +972-8-931-1900

T: +1 646-653-7030








Laine Yonker


Edison Group


E: lyonker@edisongroup.com


T: +1 646-653-7035

Cision View original content:http://www.prnewswire.com/news-releases/evogene-to-hold-virtual-investor--analyst-days-301263905.html

SOURCE Evogene

EVOGENE LTD.

NASDAQ:EVGN

EVGN Rankings

EVGN Latest News

EVGN Stock Data

35.94M
46.63M
1.66%
8.91%
0.17%
Pesticide and Other Agricultural Chemical Manufacturing
Manufacturing
Link
United States of America
Rehovot

About EVGN

evogene is a plant genomics company, utilizing a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. evogene offers a complete solution for crop productivity improvement through biotechnology and advanced breeding using a unique technology infrastructure that is based on deep scientific understandings of plant genomics and proprietary computational capabilities. the company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease), in key crops as corn, soybean, wheat and rice. in addition, evogene has earlier stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. the company's headquarters are located in rehovot, israel and is listed for trading on the tel aviv stock exchange (tase: evgn) and on the new york stock exch